Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

Big Winners (ACHN, OEH, EXEL, PHH, NPSP)

NEW YORK, November 12,2012 (MESHPRESS) –, an investment community with a  special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) shares jumped 7.13% to $9.01 in the last trading session. The company posted third quarter loss of $15.26 million or $0.20 per share from $10.44 million or $0.15 per share in the same quarter last year. The company recognized no revenue for the third quarter, compared to about $64,000 last year. Analysts had expected a loss of $0.17 per share on revenue of $50,000 for the third quarter.

 Can ACHN Bounce Back? Find Out Here

Orient-Express Hotels Ltd.(NYSE:OEH) shares climbed 6.82% to $11.27 after the company’s board rejected Indian Hotels Co.’s roughly $1.21 billion acquisition offer, calling it “deeply unattractive from a financial perspective.” Indian Hotels, which is part of the Tata Group, and a fund controlled by Italy’s Montezemolo & Partners last month made a joint bid to acquire Orient Express Hotels for $12.63 a share.

. Can OEH  Find The Bottom? Find Out Here

Exelixis, Inc.(NASDAQ:EXEL) shares climbed 6.55% to $4.88 in the previous trading session. The company posted third quarter revenues of $13.3 million, as compared to $128.3 million for the comparable period in 2011. Net (loss) income for the quarter ended September 30, 2012 was ($32.8) million, or ($0.20) per share, compared to $77.9 million, or $0.60 per share, basic, for the comparable period in 2011.

Looking forward, the company announced that it continues to expects fiscal 2012 revenues in the range of $40.0 million to $60.0 million. Analysts on an average are expecting the Company to report revenue of $45.7 million for fiscal 2012.

 Can EXEL Find The Bottom? Find Out Here

PHH Corporation(NYSE:PHH) shares increased 6.44% to $20.48 after the company reported third-quarter net loss of $42 million or $0.74 per share, as compared to $148 million or $2.62 per share in the year ago quarter. Core earnings per share declined to $0.74 from $1.14 in the year ago quarter. Net revenues for the quarter rose to $624 million from $384 million in the prior year quarter. Analysts expected the company to report earnings of $0.70 per share on revenues of $680.73 million for the quarter.

 Can PHH  Bounce Back?  Find Out Here

NPS Pharmaceuticals, Inc.(NASDAQ:NPSP) shares gained 6.40% to $9.48 in the last trading session after the company reported ($0.04) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.16) by $0.12. The company had revenue of $27.02 million for the quarter, compared to the consensus estimate of $28.18 million.

Can NPSP  Find The Bottom? Find Out Here

About Beststocksdaily team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.



Related Press realease: